This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs' Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company. The contract, valued at $5,682,190.25, is for the provision of radiopharmaceuticals to support nuclear medicine and diagnostic imaging services at the South Texas Veterans Health Care System in San Antonio, TX. The contract is an unrestricted, single-award IDC with a performance period from January 11, 2025, through January 10, 2028.
The contracted products include a variety of radioisotopes and radiopharmaceuticals such as F-18 FDG, Ga-67 Gallium Citrate, Ga-68 compounds, I-123/131 compounds, In-111 products, and Tc-99m products. These critical medical isotopes and specialized pharmaceutical products are used in nuclear medicine, oncology, and diagnostic imaging procedures for veterans. The contract requires the supplier to possess a valid Nuclear Regulatory Commission or state license and to demonstrate technical capability through past performance references. Pricing is evaluated as a significant but not predominant factor, with technical and past performance considered more important. The contract includes provisions for scheduled and emergency deliveries to ensure a reliable supply of these time-sensitive radioactive materials to VA healthcare facilities.
Generated 1/28/25, 12:04 PM